Evidence map›Paper›PMID 37948038›Full record

ArticleTherapeutic innovation & regulatory science2024

An Update from the Benchmark Survey of phactMI™ Member Companies on Providing Medical Information in the Digital Space.

Sheena Dupuy, Laura Opincar, Kirtida Pandya, Susan Wnorowski, Marianne Cuellar, Jennifer Riggins, Evelyn R Hermes-DeSantis

Abstract read
In one paragraph

Article in Therapeutic innovation & regulatory science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sheena DupuyAstraZeneca Pharmaceuticals, One MedImmune Way (Building 200), Gaithersburg, MD, 20878, USA.ORCID 0009-0001-2597-187X
Laura OpincarGlobal Medical Information & Communication, AstraZeneca Pharmaceuticals, One MedImmune Way (Building 200), Gaithersburg, MD, 20878, USA.ORCID 0009-0004-2040-1722
Kirtida PandyaMedical Affairs, Sandoz, Inc., 100 College Rd. West, Princeton, NJ, 08540, USA.ORCID 0009-0008-6381-960X
Susan WnorowskiUS Medical Information and Patient Safety, Ipsen Biopharmaceuticals, Inc, Cambridge, USA.ORCID 0000-0002-9659-4784
Marianne CuellarIpsen Biopharmaceuticals Canada Inc., 5050 Satellite Drive, Suite 500, Mississauga, ON, L4W 0G1, Canada.ORCID 0009-0005-7542-3221
Jennifer RigginsphactMI, Glen Mills, PA, USA.ORCID 0000-0002-6044-1284
Evelyn R Hermes-DeSantisphactMI, 142 Glen Mills Rd., PO Box 23, Glen Mills, PA, 19342, USA. evelyn@phactMI.org.ORCID 0000-0001-5658-3899

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe Pharma Collaboration for Transparent Medical Information (phactMI™) benchmarking survey of 32 pharmaceutical companies describes the use of technology by Medical Information Departments.

methodsA survey was distributed to phactMI™ member companies in June 2022 and included 79 closed and open-ended questions. The survey's six sections included demographics, chatbot, social media, instant messaging applications, websites, and technology.

resultsMost Medical Information Departments have implemented innovative technology since 2019 with the main driver of remaining up-to-date. A total of 94% have a Medical Information website. Of those with a Medical Information website for healthcare professionals (HCPs), 97% allow for self-authentication. Most HCP-based websites have webforms for inquiries and 1-800 numbers, while only few offer video chat, chatbot, and the ability to identify local representatives. These websites also link to clinicaltrials.gov, publications, posters, and congress materials. Only 30% have a website for patients/caregivers. Most websites are discoverable by Google™. Awareness of Medical Information Websites occurs in a variety of ways, with most using multiple strategies to reach HCPs. There is wide variation in the technology platform used for the core functions of Medical Information.

conclusionAs technology continues to advance and omnichannel content remains a key objective, Medical Information needs to remain agile and transformative in their strategic and tactical planning and execution. Based on this benchmarking survey, the authors recommend that Medical Information Departments focus on expanding services for patients/caregivers, leverage digital innovations, expanding awareness, building efficiencies in workflow through technology, and continually improving website functionalities with innovative technologies.

Indexed as

BenchmarkingSocial MediaHealth PersonnelHumansSoftwareSurveys and QuestionnairesBenchmarkingMedical InformationphactMIPharmaceutical industrySurveyTechnologyWebsites

Identifiers

PMID37948038
PMCPMC10764438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.